Reference-based pricing discussed

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.375, 2002-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reference-based pricing effect on PPIs and H2-antagonists prescribing

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Do reference-based pricing policies really contain drug costs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 320, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Reference-Based Pricing Schemes: Effect on Pharmaceutical Expenditure, Resource Utilisation and Health Outcomes

By Ioannides-Demos L.L. Ibrahim J.E. McNeil J.J.

PharmacoEconomics, Vol. 20, Iss. 9, 2002-09 ,pp. : 577-591

Adis International

Access to resources Recommend Favorite

Reference-based drug pricing in Canada in need of fine-tuning?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 394, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

A reference pricing system for Ireland

By Usher Cara Barry Michael

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 12, Iss. 6, 2012-12 ,pp. : 675-677

Informa Healthcare

Access to resources Recommend Favorite